PERNICE, Valentina
PERNICE, Valentina
A fatal case of a paint thinner ingestion: Comparison between toxicological and histological findings
2010-01-01 Argo, Antonina*; Bongiorno, David; Bonifacio, Antonino; Pernice, Valentina; Liotta, Rosa; Indelicato, Serena; Zerbo, Stefania; Fleres, Pierangela; Ceraulo, Leopoldo; Procaccianti, Paolo
Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease
2008-01-01 Rizzo, M; Pernice, V; Frasheri, A; Berneis, K
Diabetes, family history and extension of coronary atherosclerosis are strong predictors of adverse events after PTCA: a one year follow-up study. Intenational Angiology. 2004. 23(suppl.1)
2004-01-01 RIZZO M; BARBAGALLO CM; PERNICE V; PACE A; RUBINO A; NOTO D; PINTO V; PIERI D; FRASHERI A; NOTARBARTOLO A; AVERNA MR
Diabetes, family hystory and extension of coronary atherosclerosis are strong predictors of adverse events after PTCA: a one year follow-up study
2005-01-01 RIZZO M; BARBAGALLO CM; NOTO D; PACE A; CEFALU AB; PERNICE V; RUBINO A; PINTO V; PIERI D; TRAINA M; FRASHERI A; NOTARBARTOLO A; AVERNA MR
Drug eluting stents's use in patients with anatomical or clinical patterns favouring restenosis: a 6-months follow-up study. Atherosclerosis. 2005. 6(suppl.1)
2005-01-01 RIZZO M; FRASHERI A; CAMPOLO L; PERNICE V; BARONE G; NOTARBARTOLO A; AVERNA M
Effects “beyond-cholesterol” by statins: a 3-months therapy with simvastatin reduces the atherogenic lipoproteins in patients with premature coronary artery disease and in absence of the traditional cardiovascular risk factors.
2004-01-01 RIZZO M; BARBAGALLO CM; PERNICE V; RUBINO A; NOTO D; PACE A; AMATO S; CAMARDA C; PINTO V; PIERI D; FRASHERI A; NOTARBARTOLO A; AVERNA MR
EFFETTI “BEYOND CHOLESTEROL” DELLE STATINE
2004-01-01 RIZZO M; BARBAGALLO CM; PERNICE V; RUBINO A; NOTO D; PACE A; AMATO S; CAMARDA C; PINTO V; PIERI D; FRASHERI A; NOTARBARTOLO A; AVERNA MR
HS-SPME-GC/MS analysis in a fatal case of a paint thinner ingestion
2007-01-01 Indelicato, S.; Argo, A.; Bongiorno, D.; Ceraulo, L.; Pernice, V.; Zerbo, S.
INTERLEUKIN 6 PLASMA LEVELS PREDICT WITH HIGH SENSITIVITY AND SPECIFICITY CORONARY STENOSIS DETECTED BY CORONARY ANGIOGRAPHY
2007-01-01 MAGGIORE M; NOTO D; COTTONE S; CEFALU AB; VADALA A; BARBAGALLO CM; RIZZO M; PERNICE V; MINA M; FAYER F; CERASOLA G; NOTARBARTOLO A; AVERNA MR
Interleukin 6 plasma levels predict with high sensitivity and specificity coronary stenosis detected by coronary angiography
2007-01-01 NOTO, D; COTTONE, S; CEFALU', AB; VADALA', A; BARBAGALLO, CM; RIZZO, M; PERNICE V; MINA,' M; FAYER, F; CERASOLA, G; NOTARBARTOLO, A; AVERNA, M
LDL peak particle size and the extension of coronary atherosclerosis in 72 patients that underwent an angiographic exam
2004-01-01 Rizzo, M; Barbagallo, CM; Pace, A; Noto, D; Maggiore, M; Frasheri, A; Pernice, V; Barone, G; Rubino, A; Pieri, D; Notarbartolo, A; Averna, M
PEAK PARTICLE SIZE AND THE EXTENSION OF CORONARY ATHEROSCLEROSIS IN 71 PATIENTS THAT UNDERWENT AN ANGIOGRAPHIC EXAM
2004-01-01 RIZZO M; BARBAGALLO CM; PACE A; NOTO D; MAGGIORE M; FRASHERI A; PERNICE V; BARONE G; RUBINO A; PIERI D; NOTARBARTOLO A; AVERNA MR
rs629301 CELSR2 polymorphism confers a ten-year equivalent risk of critical stenosis assessed by coronary angiography
2021-01-01 Noto D.; Cefalu A.B.; Martinelli N.; Giammanco A.; Spina R.; Barbagallo C.M.; Caruso M.; Novo S.; Sarullo F.; Pernice V.; Brucato F.; Ingrassia V.; Fayer F.; Altieri G.I.; Scrimali C.; Misiano G.; Olivieri O.; Girelli D.; Averna M.
Sviluppo di metodi analitico-tossicologici per la determinazione di PCDD/F e PCB in matrice ambientale. Livelli di contaminazione per la Regione Sicilia e studio dei profili di distribuzione con trattamento statistico dei risultati.
2012-03-15 Pernice, .
The atherogenic lipoprotein phenotype as predictor of cardiovascular events in patients with non-coronary forms of atherosclerosis.
2008-01-01 Rizzo, M; Pernice, V; Frasheri, A; Rini, GB; Berneis, K
USE OF THE DRUG ELUTING STENTS WITH RAPAMICIN IN PATIENTS WITH ANATOMICAL OR CLINICAL PATTERNS FAVOURING RESTENOSIS: RESULTS OF A 6-MONTHS FOLLOW-UP ON THE FIRST 100 PATIENS.
2004-01-01 RIZZO M; FRASHERI A; CAMPOLO L; PERNICE V; BARONE G; RUBINO A; PIERI D; CATANZARO S; MINA' M; BARBAGALLO CM; NOTARBARTOLO A; AVERNA MR
Use of the drug eluting stents with rapamicin in patients with anatomical or clinical patterns favouring restenosis: results of a 6-months follow-up on the first 100 patients. Intenational Angiology. 2004. 23(suppl.1)
2004-01-01 FRASHERI A; RIZZO M; CAMPOLO L; PERNICE V; RUBINO A; PIERI D; BARONE G; PACE A; NOTO D; BARBAGALLO CM; NOTARBARTOLO A; AVERNA MR